• 
• http://www.nature.com/ncpneuro
• Editor: John W. Griffin, MD
• Volume 4: 12 issues per year
• ISSN: 1745-834X
• EISSN: 1745-8358
• Impact factor : 4.339*
• Impact ranking: 18/146 in Clinical Neurology*
• Date Established: November 2005
• Published on behalf of:

Aims and Scope:

Nature Clinical Practice Neurology is a new peer-reviewed journal for neurologists.

Nature Clinical Practice Neurology delivers timely interpretations of key developments reported in the original research, translating the latest findings into clinical practice.

Coverage includes prevention, diagnosis and treatment of disease or impaired function of the central and peripheral nervous systems, including neurodevelopmental, neurodegenerative and neuropsychiatric disorders. Content is subject to rigorous peer review.

Nature Clinical Practice Neurology is published monthly in print and online. Content includes editorial and opinion pieces, highlights from the current literature, commentaries on the application of recent research to practical patient care, comprehensive reviews, and in-depth case studies.

Readership:

Neurologists, as well as other physicians with interests in neurodevelopmental, neurodegenerative and neuropsychiatric disorders. Staff and students at academic and teaching hospitals. Commercial and government organizations involved in drug development and clinical trials.

Organized into sections, content includes:

• Editorials - thoughts from the Editor-in-Chief or his nominee.
• Viewpoints - opinion articles by leading specialists, discussing topical issues in the field.
• Research Highlights - brief summaries of important articles published in the original research journals, from the specialty-specific journals to journals in other areas that may include articles with surprising relevance to the Nature Clinical Practice journal's field of coverage.
• Practice Points - unique two-page articles based on original material published elsewhere. Each Practice Point is based on a single original research paper and includes a synopsis written by our editorial team along with a commentary by a leading authority, which puts the original article into clinical context and offers expert opinion on best practice.
• Reviews - timely, authoritative reviews of key developments, written by leading specialists. In addition to general reviews, these include the following:
• Therapy Insights - leading authorities from other specialties discuss conditions and therapies that have particular relevance to the Nature Clinical Practice journal's field of coverage.
• Drug Insights - review the information physicians and trainees need to know about a drug class.
• Mechanisms of Disease - discuss the etiology of disease.
• Technology Insights - focus on advances in treatment and diagnostic technologies and equipment, such as imaging techniques and technology-assisted surgery.
• Primer Articles - provide straightforward explanations of elements essential to understanding and evaluating original clinical research. Jargon-free and aimed at non-trialists, these foundation articles cover subjects such as statistical methods and good clinical practice.
• Case Studies - fully detailed descriptions of the etiology, diagnosis, and management of individual cases.
• Continuing Medical Education - the opportunity for physicians to earn Category 1 AMA PRA credits at no additional cost.

What makes Nature Clinical Practice stand apart from other clinical review journals?

• The Nature standards of editorial excellence are applied to the series as expected by readers, authors and institutional customers.
• World-renowned experts and opinion leaders are appointed as Editors-in-Chief to ensure content focuses on the key issues in the discipline.
• A distinguished international Advisory Board ensures accurate global coverage of the specialty and related subspecialties.
• Results-focused content provides physicians with the results of clinical trials and explains their application in practice, as opposed to lengthy research details.


Editor-in-Chief: John W. Griffin, MD Johns Hopkins University School of Medicine
Dr. Griffin is a member of the National Advisory Council to the National Institute of Neurologic Disease and Stroke. He is Chair of the Scientific Advisory Board of the Burroughs Wellcome Fund Program in Translational Research. He is Past President of the Peripheral Nerve Society and the Society for Experimental Neuropathology, and President of the American Neurological Association. His honors include the Jacob Javits Award from the NIH and multiple teaching awards, including the Professor's Award of the Johns Hopkins University School of Medicine. He has given many named lectures, including the Robert Wartenberg Lecture of the American Academy of Neurology and the Soriano Lecture of the American Neurological Association. Advisory board >>

Online features and site license access:

• Online archive available back to November 2005.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period only. Archive content not included in the license agreement is available to purchase.
• Users have access to all the online features of nature.com. Find out more >>
• Site license customers will benefit from the services available. Find out more >>
• Indexed in Chemical Abstracts Service (CAS), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Current Contents (Clinical Medicine), EMBASE, PubMed (MEDLINE) and Science Citation Index Expanded.

*2007 Journal Citation Report (Thomson Reuters, 2008)